Document is current
Any future updates will be listed below
-
Authors
Kato, Yujin
Seishima, Ryo https://orcid.org/0000-0002-8892-4173
Hattori, Kaoru
Kato, Hirochika
Ishida, Hiroki
Shigeta, Kohei
Okabayashi, Koji
Sugihara, Eiji
Takimoto, Tetsuya
Nakamura, Kohei
Nishihara, Hiroshi
Saya, Hideyuki https://orcid.org/0000-0001-6610-1902
Kitagawa, Yuko
-
Funding
Funding for this research was provided by:
JST SPRING
Sysmex Corporation
- License Information
-
More Information
Article History
Received: 2 May 2024
Revised: 20 December 2024
Accepted: 30 January 2025
First Online: 11 February 2025
Competing interests
: Yuko K received grants from TAIHO PHARMACEUTICAL CO., LTD.; CHUGAI PHARMACEUTICAL CO., LTD.; Yakult Honsha Co. Ltd.; DAIICHI SANKYO COMPANY; Merck Serono Co., Ltd; AsahiKASEI Co., Ltd; EA Pharma Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Factory Inc.; SHIONOGI & CO., LTD.; KAKEN PHARMACEUTICAL CO., LTD.; Kowa Pharmaceutical Co., Ltd.; Astellas Pharma Inc.; MEDICON INC., Dainippon Sumitomo Pharma Co., Ltd.; Taisho Toyama Pharmaceutical Co., Ltd.; Kyouwa Hakkou Kirin Co., Ltd.; Pfizer Japan Inc.; ONO PHARMACEUTICAL CO., LTD.; NIHON PHARMACEUTICAL CO., LTD.; Japan Blood Products Organization; Medtronic Japan Co., Ltd.; Sanofi K.K.; Eisai Co., Ltd; TSUMURA & CO.; KCI Licensing, Inc.; ABBOTT JAPAN CO., LTD; and FUJIFILM Toyama Chemical Co., Ltd., outside the submitted work.
: The protocol of this study was approved by The Ethics Committee of Keio University, and all methods were performed in accordance with the Helsinki Declaration of 1996 (approval number: 20150148). The Ethics Committee at the Laboratory Animal Care and Use Committee at Keio University School of Medicine approved all experimental procedures, and the study was performed in accordance with the Care and Use of Laboratory Animals (NIH). Informed consent was obtained from all individual participants included in the study.
: All authors critically reviewed and approved the final manuscript.
